523 related articles for article (PubMed ID: 18088064)
1. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
[TBL] [Abstract][Full Text] [Related]
2. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
[TBL] [Abstract][Full Text] [Related]
3. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants.
Glas J; Seiderer J; Wetzke M; Konrad A; Török HP; Schmechel S; Tonenchi L; Grassl C; Dambacher J; Pfennig S; Maier K; Griga T; Klein W; Epplen JT; Schiemann U; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Folwaczny M; Mussack T; Brand S
PLoS One; 2007 Sep; 2(9):e819. PubMed ID: 17786191
[TBL] [Abstract][Full Text] [Related]
4. Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status.
Schmechel S; Konrad A; Diegelmann J; Glas J; Wetzke M; Paschos E; Lohse P; Göke B; Brand S
Inflamm Bowel Dis; 2008 Feb; 14(2):204-12. PubMed ID: 18022867
[TBL] [Abstract][Full Text] [Related]
5. IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease.
Dubinsky MC; Wang D; Picornell Y; Wrobel I; Katzir L; Quiros A; Dutridge D; Wahbeh G; Silber G; Bahar R; Mengesha E; Targan SR; Taylor KD; Rotter JI;
Inflamm Bowel Dis; 2007 May; 13(5):511-5. PubMed ID: 17309073
[TBL] [Abstract][Full Text] [Related]
6. Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype.
Cummings JR; Ahmad T; Geremia A; Beckly J; Cooney R; Hancock L; Pathan S; Guo C; Cardon LR; Jewell DP
Inflamm Bowel Dis; 2007 Sep; 13(9):1063-8. PubMed ID: 17508420
[TBL] [Abstract][Full Text] [Related]
7. ATG16L1 and IL23R are associated with inflammatory bowel diseases but not with celiac disease in the Netherlands.
Weersma RK; Zhernakova A; Nolte IM; Lefebvre C; Rioux JD; Mulder F; van Dullemen HM; Kleibeuker JH; Wijmenga C; Dijkstra G
Am J Gastroenterol; 2008 Mar; 103(3):621-7. PubMed ID: 18047540
[TBL] [Abstract][Full Text] [Related]
8. Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis.
Büning C; Schmidt HH; Molnar T; De Jong DJ; Fiedler T; Bühner S; Sturm A; Baumgart DC; Nagy F; Lonovics J; Drenth JP; Landt O; Nickel R; Büttner J; Lochs H; Witt H
Aliment Pharmacol Ther; 2007 Oct; 26(7):1025-33. PubMed ID: 17877509
[TBL] [Abstract][Full Text] [Related]
9. IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease.
Tremelling M; Cummings F; Fisher SA; Mansfield J; Gwilliam R; Keniry A; Nimmo ER; Drummond H; Onnie CM; Prescott NJ; Sanderson J; Bredin F; Berzuini C; Forbes A; Lewis CM; Cardon L; Deloukas P; Jewell D; Mathew CG; Parkes M; Satsangi J
Gastroenterology; 2007 May; 132(5):1657-64. PubMed ID: 17484863
[TBL] [Abstract][Full Text] [Related]
10. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
[TBL] [Abstract][Full Text] [Related]
11. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease.
Heliö T; Halme L; Lappalainen M; Fodstad H; Paavola-Sakki P; Turunen U; Färkkilä M; Krusius T; Kontula K
Gut; 2003 Apr; 52(4):558-62. PubMed ID: 12631669
[TBL] [Abstract][Full Text] [Related]
12. Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease.
Nielsen OH; Rüdiger N; Gaustadnes M; Horn T
Scand J Gastroenterol; 1997 Oct; 32(10):1028-34. PubMed ID: 9361176
[TBL] [Abstract][Full Text] [Related]
13. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population.
Gazouli M; Mantzaris G; Kotsinas A; Zacharatos P; Papalambros E; Archimandritis A; Ikonomopoulos J; Gorgoulis VG
World J Gastroenterol; 2005 Feb; 11(5):681-5. PubMed ID: 15655821
[TBL] [Abstract][Full Text] [Related]
14. IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease.
Roberts RL; Gearry RB; Hollis-Moffatt JE; Miller AL; Reid J; Abkevich V; Timms KM; Gutin A; Lanchbury JS; Merriman TR; Barclay ML; Kennedy MA
Am J Gastroenterol; 2007 Dec; 102(12):2754-61. PubMed ID: 17894849
[TBL] [Abstract][Full Text] [Related]
15. CARD15 and IL23R influences Crohn's disease susceptibility but not disease phenotype in a Brazilian population.
Baptista ML; Amarante H; Picheth G; Sdepanian VL; Peterson N; Babasukumar U; Lima HC; Kugathasan S
Inflamm Bowel Dis; 2008 May; 14(5):674-9. PubMed ID: 18200510
[TBL] [Abstract][Full Text] [Related]
16. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis.
Franchimont D; Vermeire S; El Housni H; Pierik M; Van Steen K; Gustot T; Quertinmont E; Abramowicz M; Van Gossum A; Devière J; Rutgeerts P
Gut; 2004 Jul; 53(7):987-92. PubMed ID: 15194649
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease.
Nielsen OH; Kirman I; Rüdiger N; Hendel J; Vainer B
Scand J Gastroenterol; 2003 Feb; 38(2):180-5. PubMed ID: 12678335
[TBL] [Abstract][Full Text] [Related]
18. DLG5 variants in inflammatory bowel disease.
Büning C; Geerdts L; Fiedler T; Gentz E; Pitre G; Reuter W; Luck W; Buhner S; Molnar T; Nagy F; Lonovics J; Dignass A; Landt O; Nickel R; Genschel J; Lochs H; Schmidt HH; Witt H
Am J Gastroenterol; 2006 Apr; 101(4):786-92. PubMed ID: 16494592
[TBL] [Abstract][Full Text] [Related]
19. The role of the selenoprotein S (SELS) gene -105G>A promoter polymorphism in inflammatory bowel disease and regulation of SELS gene expression in intestinal inflammation.
Seiderer J; Dambacher J; Kühnlein B; Pfennig S; Konrad A; Török HP; Haller D; Göke B; Ochsenkühn T; Lohse P; Brand S
Tissue Antigens; 2007 Sep; 70(3):238-46. PubMed ID: 17661913
[TBL] [Abstract][Full Text] [Related]
20. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
